Saturday, June 21, 2025
INBV News
Submit Video
  • Login
  • Register
  • Home
  • Business
  • Entertainment
  • Health
  • Lifestyle
  • Politics
  • Sports
  • Technology
  • Travel
  • Weather
  • World News
  • Videos
  • More
    • Podcasts
    • Reels
    • Live Video Stream
No Result
View All Result
  • Home
  • Business
  • Entertainment
  • Health
  • Lifestyle
  • Politics
  • Sports
  • Technology
  • Travel
  • Weather
  • World News
  • Videos
  • More
    • Podcasts
    • Reels
    • Live Video Stream
No Result
View All Result
INBV News
No Result
View All Result
Home Technology

Newly found ‘kill switch’ triggers death of cancer cells in potential breakthrough

INBV News by INBV News
November 12, 2023
in Technology
383 16
0
Newly found ‘kill switch’ triggers death of cancer cells in potential breakthrough
548
SHARES
2.5k
VIEWS
Share on FacebookShare on Twitter

Researchers say they’ve situated a “kill switch” that may trigger the death of cancer cells.

Scientists on the UC Davis Comprehensive Cancer Center in Sacramento, California, have identified a protein on the CD95 receptor that may “program” cancer cells to die, as detailed in a study published within the journal Cell Death & Differentiation last month.

RELATED POSTS

Apple sued by shareholders for allegedly overstating AI progress

All the things we find out about Tesla’s robotaxi launch in Austin

A receptor is a protein inside a cell that receives and transmits signals.

CD95 receptors — also known as Fas — have gained the nickname “death receptors” because they send a signal that causes cancer cells to “self-destruct,” in accordance with a press release from UC Davis.

“Previous efforts to focus on this receptor have been unsuccessful. But now that we’ve identified this epitope (goal), there could possibly be a therapeutic path forward to focus on Fas in tumors,” Jogender Tushir-Singh, an associate professor within the Department of Medical Microbiology and Immunology and senior creator of the study, said in the discharge.

Experts are hopeful that future cancer drugs could boost the activity of those CD95 receptors to create a latest weapon against cancer tumors, which have been treated historically with surgery, chemotherapy and radiation.

Immune-based therapies, comparable to CAR (chimeric antigen receptor) T-cell therapy, have shown promise for a subset of patients, but have had limited effectiveness against many cancer types.


Cancer cells
Getty Images

“Despite being decently successful in liquid tumors, comparable to leukemia spectrum cancers, long-term remission stays the most important challenge for CAR T-cell therapies,” Tushir-Singh told Fox News Digital in an email. 


An employee in one of Miltenyi Biotec's clean rooms checks the tightness of a tube set in which patient cells are modified into drugs.
CD95 receptors — also known as Fas — have gained the nickname “death receptors” because they send a signal that causes cancer cells to “self-destruct,” in accordance with a press release from UC Davis.
dpa/picture alliance via Getty I

The larger challenge with this therapy — which usually costs $500,000 or more — is that it has only shown “meager success” in treating solid tumors, the researcher noted.

“Our study strongly provides a comprehensive takeaway and potential solution to rework the meager success of CAR-T therapies into potentially successful [therapies for] solid tumors.”

The newly discovered “kill switch” could terminate tumor cells while also helping to make immunotherapies simpler — “a possible one-two punch against tumors,” the discharge stated.

To date, no CD95-boosting drugs have made it into clinical trials.

“Despite many breakthroughs within the cancer immunotherapeutic field, targeting Fas stays neglected, primarily as a result of fear of retaliation against immune-system T-cells,” Tushir-Singh told Fox News Digital.

The study did have some limitations — namely, there is proscribed data from clinical trials, the researcher noted. 

Tushir-Singh identified, nevertheless, that cancer researchers can now return and collect human tumor samples from clinical trials and perform latest analyses in light of those findings.

“It is clear that the success of CAR-T therapy relies on off-target killing by Fas,” he told Fox News Digital. 

“With the present information, we researchers and doctors should screen potential cancer patients — who can be undergoing CAR-T therapy — to envision for the great presence of Fas on their tumors,” he went on. 

“If a patient lacks Fas expression in his or her tumors, we’d like to seek out ways to securely manipulate these tumors and begin making them Fas before giving costly CAR therapies. The latter would likely make the CARs stronger in long-term efficacy.”

Looking ahead, Tushir-Singh said he’s eager for the longer term of cancer treatments.

“Because of the arrival of cancer immunotherapy and other targeted therapies, cancer rates overall prior to now a long time have decreased significantly,” he said. 

“I read every single day the outstanding research that is occurring within the U.S. to beat cancer. People should stay positive.”

Added Tushir-Singh, “The subsequent breakthrough is only one experiment away.”

1

Do you trust technology Today?

Tags: breakthroughcancercellsdeathkillNewlypotentialswitchtriggers
Share219Tweet137
INBV News

INBV News

Related Posts

edit post
Apple sued by shareholders for allegedly overstating AI progress

Apple sued by shareholders for allegedly overstating AI progress

by INBV News
June 21, 2025
0

Apple was sued on Friday by shareholders in a proposed securities fraud class motion that accused it of downplaying how long...

edit post
All the things we find out about Tesla’s robotaxi launch in Austin

All the things we find out about Tesla’s robotaxi launch in Austin

by INBV News
June 21, 2025
0

Tesla's long-overdue robotaxi is finally hitting the streets this weekend, however the rollout may face some roadblocks.The Elon Musk-led electric...

edit post
ChatGPT is getting smarter, but excessive use could destroy our brains, study warns

ChatGPT is getting smarter, but excessive use could destroy our brains, study warns

by INBV News
June 20, 2025
0

Is it a man-made lack of intelligence? Not only is AI getting frighteningly smart, nevertheless it could also be making...

edit post
Meta smart glasses with Oakley and Prada, extending Luxottica deal

Meta smart glasses with Oakley and Prada, extending Luxottica deal

by INBV News
June 19, 2025
0

Meta CEO Mark Zuckerberg tries on Orion AR glasses on the Meta Connect annual event at the corporate's headquarters in...

edit post
Microsoft prepared to walk away from high-stakes talks with OpenAI: report

Microsoft prepared to walk away from high-stakes talks with OpenAI: report

by INBV News
June 19, 2025
0

Microsoft is ready to desert its high-stakes negotiations with OpenAI over the longer term of its alliance, the Financial Times reported Wednesday. The...

Next Post
edit post
Donald Trump flipped off by Bill Burr’s wife, Nia Renée Hill, at UFC match

Donald Trump flipped off by Bill Burr's wife, Nia Renée Hill, at UFC match

edit post
A UNESCO World Heritage site with 1000’s of individuals living inside it

A UNESCO World Heritage site with 1000's of individuals living inside it

CATEGORIES

  • Business
  • Entertainment
  • Health
  • Lifestyle
  • Podcast
  • Politics
  • Sports
  • Technology
  • Travel
  • Videos
  • Weather
  • World News

CATEGORY

  • Business
  • Entertainment
  • Health
  • Lifestyle
  • Podcast
  • Politics
  • Sports
  • Technology
  • Travel
  • Videos
  • Weather
  • World News

SITE LINKS

  • About us
  • Contact us
  • Privacy Policy
  • Terms and Conditions
  • Disclaimer
  • DMCA

[mailpoet_form id=”1″]

  • About us
  • Contact us
  • Privacy Policy
  • Terms and Conditions
  • Disclaimer
  • DMCA

© 2022. All Right Reserved By Inbvnews.com

No Result
View All Result
  • Home
  • Business
  • Entertainment
  • Health
  • Lifestyle
  • Politics
  • Sports
  • Technology
  • Travel
  • Weather
  • World News
  • Videos
  • More
    • Podcasts
    • Reels
    • Live Video Stream

© 2022. All Right Reserved By Inbvnews.com

Welcome Back!

Login to your account below

Forgotten Password? Sign Up

Create New Account!

Fill the forms below to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Add New Playlist